2022
DOI: 10.1038/s41586-022-04537-z
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Xist with compounds that disrupt RNA structure and X inactivation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
60
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 85 publications
(62 citation statements)
references
References 28 publications
1
60
0
1
Order By: Relevance
“…Virus-vector-based technologies, which have been available for practical use in the last few years as COVID-19 vaccines [ 142 ], should be considered for lncRNA therapy in the future. In recent years, a small molecule-based inhibitor for Xist lncRNA has been developed [ 143 ]; therefore, the application of such a method may also be considered for other lncRNAs. The third issue is the complexity of the pathogenic factors of muscle atrophy [ 15 ], and lncRNAs, which function across the entire spectrum of muscle atrophy caused by cancer cachexia, disuse, fasting, and aging, have not yet been elucidated.…”
Section: Therapeutic Potential and Limitations Of Lncrnas For Skeleta...mentioning
confidence: 99%
“…Virus-vector-based technologies, which have been available for practical use in the last few years as COVID-19 vaccines [ 142 ], should be considered for lncRNA therapy in the future. In recent years, a small molecule-based inhibitor for Xist lncRNA has been developed [ 143 ]; therefore, the application of such a method may also be considered for other lncRNAs. The third issue is the complexity of the pathogenic factors of muscle atrophy [ 15 ], and lncRNAs, which function across the entire spectrum of muscle atrophy caused by cancer cachexia, disuse, fasting, and aging, have not yet been elucidated.…”
Section: Therapeutic Potential and Limitations Of Lncrnas For Skeleta...mentioning
confidence: 99%
“…Inactivation of XIST in nuclear donor cells or its attenuation in SCNT embryos improved blastocyst rates and cloning efficiency in mice and pigs ( Matoba et al, 2011 ; Zeng et al, 2016 ; Ruan et al, 2018 ; Yang et al, 2019 ). A recent study demonstrated that the small molecule X1 can target a specific motif of Xist and blocks initiation of XCI ( Aguilar et al, 2022 ). This may represent a new alternative for preventing early inaction of X chromosome in SCNT embryos, however, more studies are needed to evaluate efficiency and toxicity in pig embryos.…”
Section: Introductionmentioning
confidence: 99%
“…IPPase is an essential component not only for cells to synthesize RNA but also for in vitro transcription (IVT) reactions. IVTs are expensive reactions that can produce large amounts of RNA, which is needed for almost all in vitro RNA biological experiments, including RNA structure-function characterization studies and the development of RNA-based therapies (8). IPPase drastically improves the yield of RNA through two different mechanisms (9).…”
Section: Introductionmentioning
confidence: 99%